Physician profile
Patrick J Edwards
NPI 1740214873
$8,587.10
in general payments reported to CMS, 2019-2025
50 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,014 · 2020: $988 · 2021: $1,755 · 2022: $1,483 · 2023: $1,213 · 2024: $679 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,346.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $979.27 | 2019-2025 | Jardiance |
| Pfizer INC. | $917.08 | 2019-2025 | |
| Abbvie INC. | $663.00 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $526.06 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $520.27 | 2019-2024 | |
| Glaxosmithkline, LLC. | $475.99 | 2019-2024 | Shingrix, Arexvy |
| Lilly USA, LLC | $446.67 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $365.53 | 2019-2023 | Glassia |
| Janssen Pharmaceuticals, INC | $362.60 | 2019-2022 | |
| Amgen INC. | $353.62 | 2019-2024 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $289.42 | 2019-2024 | Xifaxan, Trulance |
| Astellas Pharma US INC | $286.69 | 2019-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals Lp | $247.50 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $244.19 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $221.71 | 2019-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.